Case Study: Gilead Sciences achieves streamlined, data-driven large-molecule bioprocess development with Benchling

Partnering with Benchling to improve large molecule bioprocess development

Gilead, a global biopharmaceutical company, faced fragmented data and workflow silos in its Biologics process development—relying on email, Excel, and an on‑prem ELN—which made sample traceability, cross‑team collaboration, and trend analysis slow and error‑prone. The team’s goal was to boost scientist productivity, collaboration, and access to actionable data for large‑molecule process development.

By partnering with Benchling, Gilead centralized data on a single platform, standardized data capture with templates, and automated assay status tracking to enable end‑to‑end sample traceability and easy aggregation of results. The change doubled ease of data sharing, more than doubled ease of study review and forecast approval, reduced time spent on data capture/search by 63%, and improved sample and experimental data tracking by 75%, enabling faster, more data‑driven decisions and higher scientist productivity.

Gilead Sciences

Peter Huang

Executive Director, Pharmaceutical Development & Manufacturing Information Systems